This seminar series will be discussing issues of generalizability, transportability, and representation in Alzheimer’s disease (AD) diagnosis and clinical trials. We will be considering the role of AD biomarkers and other eligibility criteria in determining who enters the clinical trials and cohort studies on which we base our conclusions and clinical recommendations.
Autism, Alzheimer’s, and Parkinson’s- Connected?
Congratulations to eBrain Faculty Dr. Andrea Rosso on a significant new publication! The study, led by Jessica Rast of Drexel University, analyzed approximately 600,000 records and found that individuals with both Alzheimer's disease-related dementia and Parkinson's...








